Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cockayne syndrome type III, also known as the mild form of Cockayne syndrome, is a rare genetic disorder that causes early (premature) aging. Unlike the more severe forms of this condition, individuals with Cockayne syndrome type III can have normal growth and development. Symptoms may include sunlight sensitivity (photosensitivity), hearing loss, eye and bone abnormalities, and changes to the brain that can be seen on imaging (brain MRIs). In general, symptoms of Cockayne syndrome type III are usually not noticeable until later in childhood.
Biomarker and diagnostic research for Cockayne syndrome type 3 has been reported in the published literature.
No clinical trials have been registered for Cockayne syndrome type 3.
85 publications have been identified in PubMed for Cockayne syndrome type 3. Research spans Basic Science / Preclinical (40%), Review / Meta-Analysis (24%), and Case Report / Case Series (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 33 | 40% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 2:57 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Cockayne syndrome type 3
20 |
24% |
Patient case studies | 11 | 13% |
Testing and diagnosis research | 5 | 6% |
Disease patterns and progression | 5 | 6% |
Other research | 4 | 5% |
New treatment approaches | 3 | 4% |
Clinical study results | 1 | 1% |
Patel S (2026). [PMID: 41921730](https://pubmed.ncbi.nlm.nih.gov/41921730/). *Dev Biol*. [Review / Meta-Analysis]
Rayi A (2026). [PMID: 30725883](https://pubmed.ncbi.nlm.nih.gov/30725883/). *Unknown Journal*. [Basic Science / Preclinical]
van Sluis M (2026). [PMID: 41254380](https://pubmed.ncbi.nlm.nih.gov/41254380/). *Nat Rev Mol Cell Biol*. [Review / Meta-Analysis]
Hernandez Herrera GA (2026). [PMID: 41527836](https://pubmed.ncbi.nlm.nih.gov/41527836/). *Hum Mol Genet*. [Epidemiology / Natural History]
Bravo M (2026). [PMID: 41897370](https://pubmed.ncbi.nlm.nih.gov/41897370/). *Biomolecules*. [Review / Meta-Analysis]
Maeda K (2026). [PMID: 41033992](https://pubmed.ncbi.nlm.nih.gov/41033992/). *Intern Med*. [Case Report / Case Series]
Altintas Ö (2026). [PMID: 42079053](https://pubmed.ncbi.nlm.nih.gov/42079053/). *bioRxiv*. [Basic Science / Preclinical]
Filippi S (2026). [PMID: 41749901](https://pubmed.ncbi.nlm.nih.gov/41749901/). *Cancers (Basel)*. [Basic Science / Preclinical]
Agrawal A (2026). [PMID: 41354724](https://pubmed.ncbi.nlm.nih.gov/41354724/). *Indian J Pediatr*. [Other]
Chen P (2026). [PMID: 41114541](https://pubmed.ncbi.nlm.nih.gov/41114541/). *Curr Eye Res*. [Basic Science / Preclinical]